Literature DB >> 12069519

Respiratory syncytial virus: reverse genetics and vaccine strategies.

Peter L Collins1, Brian R Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12069519     DOI： 10.1006/viro.2002.1437

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  36 in total

1.  Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro.

Authors:  Josephine M McAuliffe; Sonja R Surman; Jason T Newman; Jeffrey M Riggs; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Virus replication in engineered human cells that do not respond to interferons.

Authors:  D F Young; L Andrejeva; A Livingstone; S Goodbourn; R A Lamb; P L Collins; R M Elliott; R E Randall
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Authors:  Luis Martinez-Sobrido; Negin Gitiban; Ana Fernandez-Sesma; Jerome Cros; Sara E Mertz; Nancy A Jewell; Sue Hammond; Emilio Flano; Russell K Durbin; Adolfo García-Sastre; Joan E Durbin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3.

Authors:  Mario Barro; John T Patton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

6.  Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.

Authors:  Roderick S Tang; Jeanne H Schickli; Mia MacPhail; Fiona Fernandes; Leenas Bicha; Joshua Spaete; Ron A M Fouchier; Albert D M E Osterhaus; Richard Spaete; Aurelia A Haller
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Respiratory syncytial virus vaccine: Is it coming?

Authors:  Valérie Sales; Elaine El Wang
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

9.  Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.

Authors:  Cynthia A Bonville; Vincent K Lau; Jordana M DeLeon; Ji-Liang Gao; Andrew J Easton; Helene F Rosenberg; Joseph B Domachowske
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.